Full-Time

Director – Global Medical Affairs

Flu Vaccines

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

70% in-office structure.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Advanced degree required (PharmD, PhD, Master’s in Biotechnology, Life Sciences or equivalent).
  • 8+ years of experience in medical affairs within the pharmaceutical or biotechnology industry, including 3+ years focused on vaccines.
  • Strong project management skills with the ability to manage multiple projects simultaneously.
  • Excellent written and verbal communication skills with the ability to present complex scientific information clearly and concisely.
  • Strong interpersonal skills with experience building relationships with KOLs and external stakeholders.
  • Proven track record of synthesizing key scientific messages with accuracy and agility, particularly in high-stakes environments related to public health and vaccine strategy.
Responsibilities
  • Develop and execute the global medical strategy for Moderna’s Flu vaccines in close collaboration with the portfolio GMAL, ensuring alignment with broader portfolio objectives and business goals.
  • Collaborate with and guide cross-functional teams to ensure that medical affairs activities are strategically integrated and operationally executed in line with the overall product strategy.
  • Oversee the planning and execution of clinical studies, real-world evidence generation, and other data generation activities related to the Flu vaccines.
  • Align data dissemination strategies for Flu vaccines with portfolio objectives, working closely with the Scientific Communications team.
  • Communicate complex scientific information effectively across all levels of the organization, including executive leadership and external stakeholders.
  • Engage strategically with key opinion leaders (KOLs), medical societies, and other external stakeholders to gather insights and support the global medical strategy for Flu vaccines. Represent Moderna at external meetings, conferences, PHDM engagements and advisory boards related to the Flu vaccines.
  • Oversee the development of global medical education initiatives, ensuring alignment with strategic objectives in collaboration with the Scientific Communications team.
  • Ensure compliance with global and local regulations, industry guidelines, and corporate policies for all medical affairs activities related to the respiratory vaccines.
  • Work closely with regional and market teams to align global strategies with local market needs and regulatory requirements, ensuring successful implementation of medical affairs activities globally.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to harness the power of mRNA to improve patient outcomes and create a new category of effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna received a $176 million contract for a bird flu vaccine.
  • The company is expanding mRNA applications to personalized cancer vaccines.
  • Moderna is establishing a domestic mRNA production facility in Australia.

What critics are saying

  • Potential backlash in Australia for bypassing vaccine safety steps.
  • Possible removal from Nasdaq 100 Index could affect investor confidence.
  • Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for new categories of medicines.
  • The company integrates AI to optimize mRNA design and production processes.
  • Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend